SecBot SecBot

MEDP

Medpace Holdings, Inc.
Nasdaq· Services-Commercial Physical & Biological Research· Inc. DE· CIK 0001668397 Biotech & Drug Discovery
$648.20 −5.74 (−0.88%)
Nov 16 4:00 PM ET · prev $653.94
Market cap
$18.4B
Large cap
Consensus
Hold
35% Buy or better · 20 analysts
Median target
$675.00
+4% · range $370.00–730.00
1 year
+10.7%
from $585.76 · Nov 17
30 days
+4.6%
from $619.66
52-week range
$393.42–692.68
−6% from high · low Apr 23
Avg volume 20D
305.4K
Oct 21 spike 1.03M
Short interest
1.38M
≈5.0% of shares · −14.2%
Days to cover
3.5
at average volume
Insider net
−$222.9M
0 buyers · 8 sellers · since Jun 30
New fund stakes
3
Q3 2026 13F · 1 exit
Filing reports
24
analyzed by SecBot
SecBot read MIXED 16 reports · 90 days
Balance 3 bearish · 2 bullish · 11 neutral oldest → newest, height = score
Avg score ·High conf. 11/16

Price

Daily candles with volume. Callouts mark insider and congressional trades, rating changes, 13F stakes, reports, catalysts, court and regulator actions, Reddit spikes and short-interest jumps. Hover one for the details (tap on phones).

Signal stack

Where each data set points today.

  • InsidersBEARISH

    8 insiders sold $222.9M.

  • InstitutionsBULLISH

    Q3 2026: 38 added (3 new), 20 trimmed or exited. Largest new: Qube Research & Technologies $99.5M, Cibc Bancorp Usa $19.2M.

  • AnalystsMIXED

    7 of 20 rate it Buy or better. Median target $675.00 (+4%).

  • Short sellersSTEADY

    Short interest −14.2% to 1.38M shares. 3.5 days to cover, ≈5.0% of shares.

  • TrendUPTREND

    3% above its 50-day average.

  • SocialQUIET

    No Reddit mentions this week. Last mention Oct 31.

Who's buying

13F· Q3 2026
3
new positions
1
exit
$129.8M
in new stakes
FundMoveSharesValue
WASATCH ADVISORS LPTRIM465,944$290.8M
Aberdeen Group plcDOUBLED2,231,252$192.5M
FMR LLCDOUBLED204,059$127.4M
CITIGROUP INCADD180,553$112.7M
Qube Research & Technologies LtdNEW159,351$99.5M
UBS Group AGTRIM116,114$72.5M
FIRST TRUST ADVISORS LPDOUBLED103,577$64.7M
Artemis Investment Management LLPDOUBLED94,503$59.0M

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

20 analysts
Hold 35% rate it Buy or better
Strong Buy2Buy5Hold13Sell0Strong Sell0
12-month targets · 13 analysts

Price is inside the target range. Median implies +4%.Targets as of Nov 17, 2026.

Recent actions
DateFirmActionRating
Oct 26, 2026BMO Capital
MAINTAIN
MAINTAINMarket Perform
Oct 23, 2026UBS
MAINTAIN
MAINTAINNeutral
Oct 23, 2026Truist Securities
MAINTAIN
MAINTAINHold
Oct 23, 2026Barclays
MAINTAIN
MAINTAINEqual-Weight
Oct 23, 2026TD Cowen
MAINTAIN
MAINTAINHold
Oct 7, 2026Mizuho
MAINTAIN
MAINTAINOutperform
Congressional trades
MEDP trades disclosed by members of Congress, with disclosure delay.
2 members · 3 buys / 1 sells
DateMemberType AmountDisclosed
May 15, 2026 David TaylorRHouse Medpace Holdings Inc BUY $1K–$15K May 28, 2026 +13d
May 15, 2026 David TaylorRHouse Medpace Holdings Inc BUY $1K–$15K May 28, 2026 +13d
Feb 26, 2026 David TaylorRHouse Medpace Holdings Inc BUY $1K–$15K Mar 6, 2026 +8d
Jan 15, 2026 Gilbert CisnerosDHouse Medpace Holdings Inc SELL $15K–$50K Feb 13, 2026 +29d

Insider ledger

Form 4
$0
bought · 0 insiders
$222.9M
sold · 8 insiders
DateInsiderTypeValue
Oct 29, 2026
EWALD STEPHEN P
General Counsel & Corp. Secy.
Oct 29, 2026
SELL$859.0K
Oct 27, 2026
BURWIG SUSAN E
Exec. VP, Operations
Oct 27, 2026
SELL$2.7M
Oct 26, 2026
BURWIG SUSAN E
Exec. VP, Operations
Oct 26, 2026
EXERCISE$54.7K
Oct 26, 2026
BURWIG SUSAN E
Exec. VP, Operations
Oct 26, 2026
SELL$10.9M
Oct 21, 2026
BURWIG SUSAN E
Exec. VP, Operations
Oct 21, 2026
EXERCISE$450.2K
Oct 12, 2026
BURWIG SUSAN E
Exec. VP, Operations
Oct 12, 2026
EXERCISE$500.2K
Oct 7, 2026
BURWIG SUSAN E
Exec. VP, Operations
Oct 7, 2026
EXERCISE$333.5K
Sep 30, 2026
Kraft Robert O.
Director
Sep 30, 2026
EXERCISE32 sh

Earnings setup

Estimates

Revision history: 🔒 Fresh data, subscribers only

PeriodEPS est.Range30D rev.Revenue
Current Q🔒 Fresh data, subscribers only
Next Q🔒 Fresh data, subscribers only
Current FY🔒 Fresh data, subscribers only
Next FY🔒 Fresh data, subscribers only
Reddit
Recent posts
All social signals and their track records

Short side

FINRA· Oct 30, 2026
1,384,347
shares short
-14.2%
vs prior settlement
3.5
days to cover
≈5.0%
of shares outstanding
Recent activity
The latest filings, insider trades, analyst actions, press and options flow, newest first.
Nov 16, 2026 SEC
🔒 Fresh report (last 24h), subscribers only
Nov 13, 2026 SEC
AQR Capital Management disclosed a 5.00% passive stake in Medpace Holdings via a new Schedule 13G filing, holding…
SC 13G · Impact 4/10
Nov 2, 2026 SEC
Two Medpace insiders (General Counsel and EVP of Operations) sold a combined $3.53M in open-market sales within a week…
CLUSTER · Impact 4/10
Oct 29, 2026 Insider
EWALD STEPHEN P sold 1,245 shares
General Counsel & Corp. Secy. @ $690.00 ($859.0K)
Oct 27, 2026 Insider
BURWIG SUSAN E sold 3,940 shares
Exec. VP, Operations @ $677.00 ($2.7M)
Oct 26, 2026 Insider
BURWIG SUSAN E acquired via exercise 328 shares
Exec. VP, Operations @ $166.73 ($54.7K)
Oct 21, 2026 Earnings result
MEDP Q3 2026 Earnings: EPS $4.84 (+7.0% vs est)
Sep 30, 2026 Inst.
WASATCH ADVISORS LP · TRIM
465,944 shares ($290.8M)
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Recent

SecBot reports

24 filings · 3 bullish · 4 bearish · 1 mixed · 16 neutral
All MEDP filing & press-release reports (24)